中国药房2016，Vol.27Issue(29)：4050-4052,4053,4.DOI:10.6039/j.issn.1001-0408.2016.29.05
肿瘤患者使用重组人粒细胞集落刺激因子DUE标准的建立与应用
Establishment and Application of the Drug Use Evaluation Criteria on Recombinant Human Granulocyte-col-ony Stimulating Factor for Cancer Patients
摘要
Abstract
OBJECTIVE:To provide reference for rational use of recombinant human granulocyte-colony stimulating factor (rhG-CSF) in cancer patients. METHODS:Referring to the expert advice and guideline of clinical application of rhG-CSF at home and abroad,DUE criteria on rhG-CSF for cancer patients was established;questionnaire was designed,and the medical re-cords of rhG-CSF in a third grade class A hospital was evaluated. RESULTS:The DUE criterion on rhG-CSF for cancer patients included 3 parts,such as drug indications,the course of medication and medication results,14 items in total. Through the imple-mentation of DUE,retrospective evaluation of 220 medical records showed that the application of rhG-CSF was up to the stan-dard in respects of drug indications,no contraindication,routine blood test and drug interaction monitoring at least twice every week,there still was irrational phenomenon. CONCLUSIONS:The established DUE criterion on rhG-CSF for cancer patients is with the characteristics of definite content,target and paracticabilitg,which can provide reference for the work development of clinical pharmacists.关键词
药物利用评价/肿瘤患者/重组人粒细胞集落刺激因子/药物利用评估标准/合理用药Key words
Drug use evaluation/Cancer patrents/Recombinant human granulocyte-colony stimulating factor/Drug use evalu-ation criteria/Rational drug use分类
医药卫生引用本文复制引用
晏妮,吴胜林,杜霞,王懿睿,王霞..肿瘤患者使用重组人粒细胞集落刺激因子DUE标准的建立与应用[J].中国药房,2016,27(29):4050-4052,4053,4.基金项目
武汉药学会医院药学科研基金生物药学项目 （）
